文献速递乳腺PETCT

18F-FDG PET-CT 检出乳腺偶发高代谢病灶的诊断特征与临床相关性:回顾性评估

Diagnostic Characteristics and Clinical Relevance of Incidental Hypermetabolic Breast Lesions Detected on 18F-FDG PET-CT: A Retrospective Evaluation.
PubMed 文献 · Acad Radiol · 2024-12-18

该研究回顾性分析了2018年1月1日至2024年1月1日间因非乳腺指征行18F-FDG PET-CT的12633例次检查,纳入符合标准的101个乳腺偶发瘤病灶(良性81个、恶性20个)。结果显示BI-RADS≥4的敏感度为100%、特异度67%、准确率73.3%,SUVmax≥3的敏感度75%、特异度69%、准确率69.3%,BI-RADS与SUVmax的阴性预测值最高(分别为100%和92%),病灶大小和患者年龄与恶性率无显著差异(p>0.05)。结论认为乳腺偶发FDG摄取病灶存在恶性风险,需进行影像学评估,SUVmax阴性预测值高,可与BI-RADS联合用于患者筛选和资源管理。

要点

  • BI-RADS≥4的敏感度为100%,特异度67%,阴性预测值100%。
  • SUVmax≥3的敏感度75%,特异度69%,阴性预测值92%。
  • 病灶大小和患者年龄与恶性率无显著差异(p>0.05)。

核心结论

  • 乳腺偶发FDG摄取病灶存在恶性风险,需进行影像学评估,SUVmax阴性预测值高,可与BI-RADS联合用于患者筛选和资源管理。

研究设计与样本

  • 回顾性评估,纳入2018年1月1日至2024年1月1日间因非乳腺指征行18F-FDG PET-CT的12633例次检查,最终纳入101个乳腺偶发瘤病灶(良性81个、恶性20个),纳入标准为病灶接受过乳腺影像、组织学诊断或至少2年影像随访。

诊断标准与关键数值

  • SUVmax≥3的敏感度75%、特异度69%、准确率69.3%;SULmax≥2的敏感度70%、特异度69%、准确率68.3%;SUVavg≥0.735的敏感度75%、特异度62%、准确率62.4%;SULavg≥0.48的敏感度70%、特异度62%、准确率61.4%;BI-RADS≥4的敏感度100%、特异度67%、准确率73.3%;BI-RADS和SUVmax的阴性预测值最高,分别为100%和92%。

临床应用与阅片要点

  • 对因非乳腺指征行18F-FDG PET-CT检出的乳腺偶发高代谢病灶,需进行影像学评估;SUVmax阴性预测值高,可与BI-RADS评估联合用于患者筛选和资源管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The study aimed to evaluate demographic and radiological characteristics of breast incidentalomas found on 18-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) performed for extramammary indications.

MATERIALS AND METHODS: A total of 12633 18F-FDG PET-CT scans performed between January 1, 2018 and January 1, 2024, were retrospectively reviewed. Breast incidentalomas that had undergone breast imaging, tissue diagnosis, or at least 2-year radiological follow-up were included. Demographic data and lesion size were recorded. Maximum and average standardized uptake values (SUVmax-SUVavg) and SUV corrected for lean body mass (SUL) were calculated using region of interest (ROI).

RESULTS: The inclusion criteria were met in 101 lesions (81 benign and 20 malignant). The most common benign lesion was fibroadenoma (n = 21), followed by stable lesions during follow-up (n = 18) and benign breast parenchyma (n = 11). The most common malignant lesion was invasive ductal carcinoma (n = 11). The diagnostic characteristics of SUVmax≥ 3, SULmax≥ 2, SUVavg≥ 0.735, SULavg≥ 0.48, and BI-RADS≥ 4 were 75%, 70%, 75%, 70% and 100% for sensitivity, 69%, 69%, 62%, 62% and 67% for specificity, and 69.3%, 68.3%, 62.4%, 61.4% and 73.3% for accuracy, respectively. The highest negative predictive values (NPV) were obtained with BI-RADS and SUVmax (100% and 92%, respectively). No significant difference in malignancy rate was observed for the lesion size and age of the patients (p > 0.05).

CONCLUSION: There is a risk of detecting malignancy in incidental lesions showing 18F-FDG uptake. Radiological workup must be done, but SUVmax, with a high NPV value, can be used in conjunction with BI-RADS assessment for appropriate patient selection and effective management of resources.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Kayadibi Y, Karagoz SH, Kurt SA, et al. Diagnostic Characteristics and Clinical Relevance of Incidental Hypermetabolic Breast Lesions Detected on 18F-FDG PET-CT: A Retrospective Evaluation. Acad Radiol. 2024. PMID: 39701843. doi:10.1016/j.acra.2024.11.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。